GSE202434 GSE202438 talazoparib 12 v 11 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE202434_GSE202438_talazoparib_12_v_11_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE202434_GSE202438_talazoparib_12_v_11_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE202434_GSE202438_talazoparib_12_v_11_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE202434_GSE202438_talazoparib_12_v_11_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 3

Gene

small nucleolar RNA host gene 16

Gene

small nucleolar RNA host gene 4

Gene

Pvt1 oncogene

Gene

cytoskeleton regulator RNA

Gene

small nucleolar RNA host gene 7

Gene

long intergenic non-protein coding RNA, p53 induced transcript

Gene

lung cancer associated transcript 1

Gene

ABCF2-H2BK1 readthrough

Gene

SLC16A1 antisense RNA 1

  • Gene

    small nucleolar RNA host gene 3


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    small nucleolar RNA host gene 4



  • Gene

    cytoskeleton regulator RNA


  • Gene

    small nucleolar RNA host gene 7


  • Gene

    long intergenic non-protein coding RNA, p53 induced transcript


  • Gene

    lung cancer associated transcript 1


  • Gene

    ABCF2-H2BK1 readthrough


  • Gene

    SLC16A1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.